Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulosclerosis, Focal Segmental | 9 | 2020 | 45 | 1.440 |
Why?
|
| Zenker Diverticulum | 5 | 2024 | 13 | 1.020 |
Why?
|
| Mycophenolic Acid | 6 | 2020 | 118 | 0.670 |
Why?
|
| Dexamethasone | 5 | 2020 | 380 | 0.570 |
Why?
|
| Immunosuppressive Agents | 5 | 2020 | 854 | 0.460 |
Why?
|
| Proteinuria | 4 | 2020 | 99 | 0.290 |
Why?
|
| Prospective Studies | 10 | 2024 | 7739 | 0.210 |
Why?
|
| Cyclosporine | 3 | 2020 | 265 | 0.210 |
Why?
|
| Diverticulum, Esophageal | 1 | 2022 | 4 | 0.200 |
Why?
|
| Diverticulum | 1 | 2022 | 12 | 0.200 |
Why?
|
| Nephrotic Syndrome | 1 | 2023 | 39 | 0.190 |
Why?
|
| Pharyngeal Diseases | 1 | 2022 | 16 | 0.190 |
Why?
|
| Esophageal Diseases | 1 | 2022 | 28 | 0.190 |
Why?
|
| Nephrology | 1 | 2023 | 61 | 0.190 |
Why?
|
| Muscular Diseases | 1 | 2022 | 112 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2023 | 279 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 3 | 2020 | 750 | 0.160 |
Why?
|
| Drug Therapy, Combination | 3 | 2012 | 1040 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2023 | 406 | 0.150 |
Why?
|
| Quality of Life | 1 | 2010 | 2999 | 0.140 |
Why?
|
| Length of Stay | 1 | 2023 | 1254 | 0.140 |
Why?
|
| Community Health Centers | 1 | 2018 | 63 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 2 | 2020 | 596 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2020 | 533 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2024 | 11120 | 0.120 |
Why?
|
| Cyclosporins | 1 | 2015 | 71 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2015 | 36 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 78 | 0.110 |
Why?
|
| Health Education | 1 | 2018 | 357 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2012 | 150 | 0.100 |
Why?
|
| Medicaid | 1 | 2018 | 451 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2023 | 5799 | 0.100 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2012 | 15 | 0.100 |
Why?
|
| Young Adult | 7 | 2020 | 13673 | 0.100 |
Why?
|
| Child | 9 | 2023 | 22308 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2012 | 11457 | 0.090 |
Why?
|
| Complement Activation | 1 | 2015 | 415 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2024 | 213 | 0.090 |
Why?
|
| Adolescent | 8 | 2020 | 22007 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2023 | 2797 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 338 | 0.090 |
Why?
|
| Pulse Therapy, Drug | 1 | 2010 | 7 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 521 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 1556 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 688 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2010 | 803 | 0.070 |
Why?
|
| Humans | 16 | 2024 | 141187 | 0.070 |
Why?
|
| Female | 11 | 2024 | 75515 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2010 | 1020 | 0.070 |
Why?
|
| Male | 10 | 2024 | 69783 | 0.070 |
Why?
|
| Remission Induction | 2 | 2020 | 309 | 0.060 |
Why?
|
| Creatinine | 2 | 2020 | 489 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1482 | 0.060 |
Why?
|
| Adult | 6 | 2015 | 39177 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2011 | 1748 | 0.050 |
Why?
|
| Pharyngeal Muscles | 1 | 2023 | 5 | 0.050 |
Why?
|
| Hernia, Hiatal | 1 | 2024 | 40 | 0.050 |
Why?
|
| Research Design | 1 | 2010 | 1143 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 1261 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 6956 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 157 | 0.050 |
Why?
|
| United States | 4 | 2018 | 15220 | 0.050 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2022 | 7 | 0.050 |
Why?
|
| Esophagus | 1 | 2024 | 257 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2023 | 771 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2020 | 18 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 24574 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1110 | 0.040 |
Why?
|
| Disease Progression | 2 | 2020 | 2793 | 0.040 |
Why?
|
| Partnership Practice | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cost Control | 1 | 2018 | 37 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 358 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 5929 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 34434 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 102 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2018 | 112 | 0.030 |
Why?
|
| Medicine | 1 | 2018 | 125 | 0.030 |
Why?
|
| Complement C5b | 1 | 2015 | 5 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2892 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2902 | 0.030 |
Why?
|
| Apolipoprotein L1 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 528 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2015 | 3490 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 530 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 658 | 0.020 |
Why?
|
| Hypoalbuminemia | 1 | 2012 | 31 | 0.020 |
Why?
|
| Health Planning | 1 | 2012 | 46 | 0.020 |
Why?
|
| Research Report | 1 | 2012 | 86 | 0.020 |
Why?
|
| Geography | 1 | 2012 | 201 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4073 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 7856 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 505 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 418 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 908 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 1016 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1859 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 501 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2070 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2018 | 1799 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2599 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5200 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 3292 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 16273 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 4174 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 10438 | 0.010 |
Why?
|